Some shareholders support acquisition of rare disease specialist Alexion
Home/FT/AstraZeneca shares fall on investor concern over $39bn deal FT AstraZeneca shares fall on investor concern over $39bn deal Financial Times0 Less than a minute Facebook X LinkedIn Some shareholders support acquisition of rare disease specialist Alexion Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on WhatsApp (Opens in new window) WhatsApp Click to email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
